Natalie Anne Marie Furney
CIK: 0002111535
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)1 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
TAK
TAKEDA PHARMACEUTICAL CO LTD
Officer
Discretionary Trading P&L
Holdings
About Furney Natalie Anne Marie
Furney Natalie Anne Marie (SEC CIK 0002111535) files insider reports with the SEC as Global General Counsel of TAKEDA PHARMACEUTICAL CO LTD (TAK).
Signal8 holds 3 ownership filings by Furney Natalie Anne Marie (1 Form 3, 2 Form 4), filed between Mar 18, 2026 and Aug 12, 2026. Those filings report 2 transactions, from Jul 1, 2026 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Furney Natalie Anne Marie's filings is in CAMBRIDGE, MA.
Recent filings by Furney Natalie Anne Marie
Other insiders filing for TAKEDA PHARMACEUTICAL CO LTD (TAK)
- Duprey Lauren Rusckowski, Chief Transformation Officer
- Plump Andrew Stewart, President, R&D
- Greenway Nicola Deidre Petal, Chief Human Resources Officer
- Farajallah Awny Samaan Botros, Chief Medical Officer
- Ibrahim Ramy Riad Ahmed, President, PDT BU
- Pacheco Rhonda Janice, President, U.S. Business Unit